Biologics

Roger Härtl, MD, has devoted much of his career to finding the best, least invasive treatment for back and neck pain. That mission has led him to research and innovate in the field of spinal biologics.

Konica Minolta Healthcare Americas partnered with RegenLab USA Feb. 19 to distribute its regenerative medicine portfolio for the orthopedic market in the U.S. and Canada.

Early-stage research published in npg Regenerative Medicine demonstrated that two medications on the market can enhance the body's ability to heal by releasing stem cells from bone marrow, reports Science Blog.

Neel Anand, MD, serves as professor of orthopedic surgery and director of spine trauma at the Cedars-Sinai Spine Center in Los Angeles.

Biopharmaceutical company MicroCures partnered Feb. 19 with the Henry M. Jackson Foundation for the Advancement of Military Medicine to study spinal cord regeneration after trauma.

Steven Cyr, MD, is a fellowship-trained spine surgeon who recently began providing stem cell treatments at SASpine in San Antonio.

Frank Phillips, MD, is the director of the section of minimally invasive spine surgery and director of the division of spine surgery at Chicago-based Rush University Medical Center.

Several clinical trials in China have been put on hold due to the coronavirus outbreak, including a treatment for a type of spondyloarthritis, according to Reuters.

This year marks the 15th anniversary of orthobiologic physician group Regenexx.

Onkos Surgical on Feb. 6 launched GenVie Magnesium Bone Scaffold, a magnesium-based bone void filler for orthopedic conditions.